Information Journal Paper
APA:
Copy. (2017). Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of Fcε RI-positive cells in the skin. THERANOSTICS, 7(5), 1266-1276. SID. https://sid.ir/paper/771878/en
Vancouver:
Copy. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of Fcε RI-positive cells in the skin. THERANOSTICS[Internet]. 2017;7(5):1266-1276. Available from: https://sid.ir/paper/771878/en
IEEE:
Copy, “Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of Fcε RI-positive cells in the skin,” THERANOSTICS, vol. 7, no. 5, pp. 1266–1276, 2017, [Online]. Available: https://sid.ir/paper/771878/en